<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> WSJ880729-0037 </DOCNO><HL> Business Brief: Avon Products Inc. </HL><SO> </SO><CO> AVP </CO><IN> HHP ERN TNM </IN><TEXT>   Avon Products Inc., New York, reported a second-quarter net loss of $82.4 million, citing $120 million of losses from its discontinued Foster Medical health care division.    The beauty products company earned $41.5 million, or 59 cents a share, a year earlier. Profit from continuing operations rose 3.3% to $37.6 million, or 53 cents a share, from $36.4 million, or 52 cents a share. Sales rose 18% to $752.9 million from $640.3 million.    In composite trading on the New York Stock Exchange yesterday, Avon's stock closed at $24.50 a share, up 37.5 cents.    The company said it is continuing to negotiate the sale of Foster Medical to Abbey Medical Inc., a subsidiary of VenTech Healthcare Corp., Toronto. Earlier, Avon said it expected to sell Foster Medical division for about $225 million in cash, stock and notes. Avon, which is returning its focus to its beauty businesses, said it hopes by year-end to shed the rest of its Health Care Services Group, composed of Mediplex and Retirement Inns of America, which may result in a loss. </TEXT></DOC>